Microsulis MEA System Labeling Changes Gain OB-GYN Panel’s Support
This article was originally published in The Gray Sheet
Users of the Microsulis MEA microwave endometrial ablation system should be trained by experienced physicians, FDA's Obstetrics & Gynecology Devices Panel recommended June 10
You may also be interested in...
U.S. commercial use of minimally invasive microwave endometrial ablation device for uterine lining ablation commences Oct. 6 following PMA approval Sept. 23. Microsulis is training physicians on the device, as was recommended in a June FDA approval condition (1"The Gray Sheet" June 16, 2003, p. 28)...
Operation Warp Speed will hold back initial shipments to ensure two-dose regimens can be completed; 15 December is ‘chalk’ target date for emergency authorization of Pfizer vaccine, OWS’ Gustave Perna says, calling it only a projection that does not impinge on FDA authority. Sending only half shipments also eases burden on cold shortage capacity at state and local level, he says.